OCCURRENCE OF PRODUCTS OF PROGASTRIN-RELEASING PEPTIDE IN HUMAN TUMORS

被引：0
|
作者：
BJORNSKOVBARTHOLDY, L [1 ]
JUVIC, J [1 ]
SCOPSI, L [1 ]
HOLST, JJ [1 ]
机构：
[1] UNIV COPENHAGEN,PANUM INST,DEPT MED PHYSIOL C,DK-2200 COPENHAGEN,DENMARK
来源：
REGULATORY PEPTIDES | 1992年 / 40卷 / 02期
关键词：
D O I：
10.1016/0167-0115(92)90144-J
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers (vol 35, 010702, 2025)
    Begolli, Gramos
    Lukic, Maja
    Rumora, Lada
    Corak, Lorna
    Dugac, Andrea Vukic
    Jakopovic, Marko
    Samarzija, Miroslav
    Tomas, Ilijan
    Knezevic, Jelena
    Debeljak, Zeljko
    BIOCHEMIA MEDICA, 2025, 35 (01)
  • [42] GASTRIN RELEASING PEPTIDE IN HUMAN NEUROENDOCRINE TUMORS
    BOSTWICK, DG
    BENSCH, KG
    JOURNAL OF PATHOLOGY, 1985, 147 (04): : 237 - 244
  • [43] Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer
    Yamaguchi, Hiroyuki
    Soda, Hiroshi
    Kitazaki, Takeshi
    Nakano, Hirofumi
    Fujino, Satoru
    Nakamura, Yoichi
    Kohno, Shigeru
    RESPIROLOGY, 2007, 12 (01) : 137 - 139
  • [44] ENZYME-IMMUNOASSAY OF IMMUNOREACTIVE PROGASTRIN-RELEASING PEPTIDE(31-98) AS TUMOR-MARKER FOR SMALL-CELL LUNG-CARCINOMA - DEVELOPMENT AND EVALUATION
    AOYAGI, K
    MIYAKE, Y
    URAKAMI, K
    KASHIWAKUMA, T
    HASEGAWA, A
    KODAMA, T
    YAMAGUCHI, K
    CLINICAL CHEMISTRY, 1995, 41 (04) : 537 - 543
  • [45] GASTRIN-RELEASING PEPTIDE IN HUMAN NEUROENDOCRINE TUMORS
    BOSTWICK, DG
    ROTH, KA
    EVANS, CJ
    BARCHAS, JD
    BENSCH, KG
    LABORATORY INVESTIGATION, 1984, 50 (01) : A6 - A6
  • [46] Excretion of progastrin products in human urine
    Hansen, CP
    Goetze, JP
    Stadil, F
    Rehfeld, JF
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 276 (04): : G985 - G992
  • [47] Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
    Korse, Catharina M.
    Taal, Babs G.
    Vincent, Andrew
    van Velthuysen, Marie-Louise F.
    Baas, Paul
    Buning-Kager, Johanna C. G. M.
    Linders, Theodora C.
    Bonfrer, Johannes M. G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (05) : 662 - 671
  • [48] Progastrin Releasing Peptide in Serum and Plasma from SCLC Patients and Normal Individuals
    Nordlund, Marianne S.
    Warren, David J.
    Bjerner, Johan
    Nustad, Kjell
    Paus, Elisabeth
    TUMOR BIOLOGY, 2008, 29 : 28 - 28
  • [49] Plasma progastrin-releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis-targeted agents in patients with metastatic castration-resistant prostate cancer
    Yashi, Masahiro
    Nishihara, Daisaku
    Yokoyama, Megumi
    Fuchizawa, Hirotaka
    Okazaki, Akihito
    Takei, Kohei
    Suzuki, Issei
    Sakamoto, Kazumasa
    Kijima, Toshiki
    Kobayashi, Minoru
    Kamai, Takao
    CANCER REPORTS, 2023, 6 (03)
  • [50] Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide
    Qader, Abed Abdel
    Urraca, Javier
    Torsetnes, Silje Boen
    Tonnesen, Finn
    Reubsaet, Leon
    Sellergren, Boerje
    JOURNAL OF CHROMATOGRAPHY A, 2014, 1370 : 56 - 62
12345